Lianbio-ADRLIANY

13F holders, Q4 2024 (December 31)
2holders
0new positions
0sold out
$0.26avg. 13F price*

At the end of Q4 2024, 2 institutions reported holding Lianbio-ADR (LIANY) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($39K) and FNY Investment Advisers, LLC ($3K).

Company
Lianbio-ADR
CUSIP
53000N108
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q1 2024: 3Q1 2024Q2 2024: 2Q2 2024Q3 2024: 2Q3 2024Q4 2024: 2Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q3 2024 → Q4 2024: 400 shares bought, net +400 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Rhumbline Advisers 0.00% No change 147,721 $39K
FNY Investment Advisers, LLC 0.00% Add +2.9% 14,200 $3K

"% of holder's portfolio" is LIANY's weight in each manager's 13F, not the share of Lianbio-ADR the manager owns.